Blood Cancer Therapeutics Laboratory
Blood Cancer Therapeutics Laboratory's research seeks to evaluate novel ways to treat haematological malignancies, with a particular focus on leukaemia, lymphoma and multiple myeloma. By determining the molecular mechanisms underpinning specific blood cancers, we are developing novel therapeutic strategies for translation into clinical trials. Our location within the Monash Health Translation Precinct uniquely places the laboratory in a position to develop our scientific discoveries from bench to bedside.
Major themes include: epigenetic therapies, lymphoma genomics, liquid biopsy, novel small molecule development and rational targeting of the MYC oncogene.
Group Head
Video presentation (1.33min) A/Prof Jake Shortt and Dr Sam Greenall talk about how they are working towards developing new therapies for haematological cancers. Published by BioCurate.
Meet the team
Researchers
- Dr Daniella Brasacchio
- Dr Sameer Greenall
- Professor Jake Shortt
- Dr Olivia Susanto
- Dr Mark Waltham
- Dr Danielle Oh
Other staff and students
Research Assistant
- Belinda Maher
PhD student
- Jackson He